Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature

Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries

Lindsey M. Hoffman, Sophie E. M. Veldhuijzen van Zanten, Niclas Colditz et al. · Journal of Clinical Oncology · 2018 · 435 citations · Full text

Medicine, Oncology, Pediatrics +15

Whole-Genome Profiling of Pediatric Diffuse Intrinsic Pontine Gliomas Highlights Platelet-Derived Growth Factor Receptor α and Poly (ADP-ribose) Polymerase As Potential Therapeutic Targets

Maryam Zarghooni, Ute Bartels, Eric Lee et al. · Journal of Clinical Oncology · 2010 · 313 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +17

Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group

Geert O. Janssens, Lorenza Gandola, Stéphanie Bolle et al. · European Journal of Cancer · 2017 · 157 citations

Medicine, Oncology, Radiation Oncology +14

ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma.

Richard J. Gilbertson, D. Ashley Hill, Roberto Hernán et al. · PubMed · 2003 · 132 citations

Medicine, Oncology, Pathology +17

Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood

Maura Massimino, Veronica Biassoni, Rosalba Miceli et al. · Journal of Neuro-Oncology · 2014 · 99 citations

Medicine, Oncology, Radiation Oncology +12